Harnessing science to create novel pain medicines from unique cultivars
We believe cannabis is changing the way pain could be managed for millions of Australian and international patients who suffer with chronic pain and neuropathic pain everyday.
The TGA has recommended to physicians that opiates are now not to be a recommended prescription medicine for pain patients, we believe that cannabis may be a good 2nd line therapy for pain patients worldwide. We plan to run clinical studies to provide evidence to prove it.
We also believe that there are exciting developments to be made around the chemicals within the plant that could help with pain. Cymra Life Sciences is researching all compounds of the plant and testing in formulations to understand how they may work in synergy to improve inflammation and pain.
Our goal is to breed unique cultivars from growers that produce higher yields, reduce risk and specific chemicals for pain.
What makes us different?
We use tissue culture propagation methods to create unique high health cultivars free from pests & diseases for our cultivation partners.
Our products and clinical development plan are based on extracts which preserve the balance of the whole plant and target chronic and neuropathic pain.
Our team are world class leaders in pharmaceuticals, plant breeding, genetics, tissue culture and drug development
How we can help you.
Understand our medical cannabis clinical trial, products, along with dosing and administration advice